Article Information
History
- June 12, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Division of Viral Products, Food and Drug Administration, Silver Spring, MD, United States of America
- ↵#Corresponding author:
Dr. Gabriel I. Parra, 10903 New Hampshire Avenue, Building 52/72, Room 1376, Silver Spring, MD 20993, Phone: +1-240-4026935, Fax: +1-301-5951070, Email: gabriel.parra{at}fda.hhs.gov
↵* These authors contributed equally to this manuscript